{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:56:04Z","timestamp":1790398564286,"version":"4.1.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2016,3,26]],"date-time":"2016-03-26T00:00:00Z","timestamp":1458950400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Teijin Pharma Ltd."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s10147-016-0971-3","type":"journal-article","created":{"date-parts":[[2016,3,26]],"date-time":"2016-03-26T04:39:20Z","timestamp":1458967160000},"page":"996-1003","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Efficacy and safety of febuxostat for prevention of tumor lysis syndrome in patients with malignant tumors receiving chemotherapy: a phase III, randomized, multi-center trial comparing febuxostat and allopurinol"],"prefix":"10.1007","volume":"21","author":[{"given":"Kazuo","family":"Tamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasukazu","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Kiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Maemondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Gemba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumichi","family":"Fujimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Kirito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Fujisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,26]]},"reference":[{"key":"971_CR1","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","volume":"26","author":"B Coiffier","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH et al (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26:2767\u20132778","journal-title":"J Clin Oncol"},{"key":"971_CR2","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1365-2141.2010.08143.x","volume":"149","author":"MS Cairo","year":"2010","unstructured":"Cairo MS, Coiffier B, Reiter A et al (2010) TLS Expert Panel. Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol 149:578\u2013586","journal-title":"Br J Haematol"},{"key":"971_CR3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/bjh.13403","volume":"169","author":"GL Jones","year":"2015","unstructured":"Jones GL, Will A, Jackson GH et al (2015) Guidelines for the management of tumour lysis syndrome in adults and children with haematological malignancies on behalf of the British Committee for Standards in Haematology. Br J Haematol 169:661\u2013671","journal-title":"Br J Haematol"},{"key":"971_CR4","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s40264-013-0084-0","volume":"36","author":"SN Ramasamy","year":"2013","unstructured":"Ramasamy SN, Korb-Wells CS, Kannangara DR et al (2013) Allopurinol hypersensitivity: a systematic review of all published cases, 1950-2012. Drug Saf 36:953\u2013980","journal-title":"Drug Saf"},{"key":"971_CR5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s40264-014-0255-7","volume":"38","author":"KC Allen","year":"2015","unstructured":"Allen KC, Champlain AH, Cotliar JA et al (2015) Risk of anaphylaxis with repeated courses of rasburicase: a Research on Adverse Drug Events and Reports (RADAR) project. Drug Saf 38:183\u2013187","journal-title":"Drug Saf"},{"key":"971_CR6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.ajkd.2013.02.378","volume":"62","author":"MA Lopez-Olivo","year":"2013","unstructured":"Lopez-Olivo MA, Pratt G, Palla SL et al (2013) Rasburicase in tumor lysis syndrome of the adult: a systematic review and meta-analysis. Am J Kidney Dis 62:481\u2013492","journal-title":"Am J Kidney Dis"},{"key":"971_CR7","first-page":"7287","volume":"34","author":"M Takai","year":"2014","unstructured":"Takai M, Yamauchi T, Ookura M et al (2014) Febuxostat for management of tumor lysis syndrome including its effects on levels of purine metabolites in patients with hematological malignancies - a single institution\u2019s, pharmacokinetic and pilot prospective study. Anticancer Res 34:7287\u20137296","journal-title":"Anticancer Res"},{"key":"971_CR8","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1186\/2193-1801-3-501","volume":"3","author":"K Maie","year":"2014","unstructured":"Maie K, Yokoyama Y, Kurita N et al (2014) Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome. SpringerPlus 3:501","journal-title":"SpringerPlus"},{"key":"971_CR9","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1093\/annonc\/mdv317","volume":"26","author":"M Spina","year":"2015","unstructured":"Spina M, Nagy Z, Ribera JM et al (2015) FLORENCE: a randomized, double blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk. Ann Oncol 26:2155\u20132161","journal-title":"Ann Oncol"},{"key":"971_CR10","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1002\/sim.5418","volume":"31","author":"J Lebowitsch","year":"2012","unstructured":"Lebowitsch J, Ge Y, Young B et al (2012) Generalized multidimensional dynamic allocation method. Stat Med 31:3537\u20133544","journal-title":"Stat Med"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-0971-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-016-0971-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-0971-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-016-0971-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:37:42Z","timestamp":1559111862000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-016-0971-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,26]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["971"],"URL":"https:\/\/doi.org\/10.1007\/s10147-016-0971-3","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,26]]}}}